Carvedilol ๐
Related Subjects:
|Hypertension
|Acute Heart Failure
|Chronic Heart Failure
๐ Carvedilol was the first beta-blocker proven to improve survival in heart failure.
๐ About
Always check the BNF link here for updated guidance.
- Non-selective ฮฒ-blocker (blocks both ฮฒ1 and ฮฒ2 receptors).
- Also blocks ฮฑ1-receptors โ causes peripheral vasodilation, reducing afterload.
- Particularly useful in heart failure with reduced ejection fraction (HFrEF).
๐ฏ Indications & Dosing Carvedilol (Oral)
- ๐ฉธ Hypertension / Angina / Post-MI:
Start 12.5 mg once daily โ increase gradually to 25 mg twice daily (max) as tolerated.
- โค๏ธ Heart Failure (HFrEF):
Start 3.125 mg twice daily โ titrate slowly (every 2โ4 weeks) up to 25 mg twice daily (max).
Always start low and go slow โ risk of initial decompensation.
โ Contraindications
- Asthma, COPD, or active bronchospasm ๐ซ.
- 2nd or 3rd-degree heart block.
- Bradycardia (<60 bpm) or systolic BP <100 mmHg.
- Uncontrolled / acute decompensated heart failure.
- Diabetes (especially with thiazide use โ may worsen glycaemic control).
- Sick sinus syndrome.
- Severe peripheral vascular disease ๐ฆต.
โ ๏ธ Side Effects
- Fatigue, lethargy, cold peripheries ๐ฅถ.
- Postural hypotension, dizziness, diarrhoea.
- Bradycardia, worsening heart failure (initially).
- Worsening diabetic control (masks hypoglycaemia).
- Claudication, impotence, insomnia.
- May exacerbate psoriasis.
๐ Interactions
- May increase ciclosporin toxicity (monitor levels closely).
- Caution with other negative chronotropes (e.g. digoxin, verapamil, diltiazem) โ risk of heart block.
๐ References